Programme
Due to the decision to hold EUROTOX 2021 as a virtual congress, the programme is currently being revised and will be published here shortly.
| Sunday, 26 September 2021 | |||||||||||||||||||||||
| 08h00–21h00 | Congress registration | 16h00–21h00 Exhibition | |||||||||||||||||||||
| 09h30–16h00 | Excursion and workshop by Ellegaard Göttingen Minipigs |
||||||||||||||||||||||
| 10h30–16h00 | Continuing Education Courses (CEC), including welcome coffee & lunch and afternoon coffee break | ||||||||||||||||||||||
|
CEC01 Thyroid hormones, brain development and toxicity testing |
CEC02 Advances in conducting systematic reviews for chemical assessment: automation, uncertainty assessment and synthesis |
CEC03 Lessons learned and future directions for toxicology in water safety and security |
CEC04 Inflammation as a mediator of toxic responses |
CEC05 Nanotoxicology |
CEC06 Toxicity assessment in drug development |
||||||||||||||||||
| 16h00 | Opening of the Exhibition | ||||||||||||||||||||||
| 17h00–19h00 |
Opening Ceremony including Keynote Lecture 01 and EUROTOX Merit Award K 01: Toxicology as a science of the known with visions of the unknown Philippe Grandjean, University of Southern Denmark, Denmark and Harvard School of Public Health, Boston, US |
||||||||||||||||||||||
| 19h00–21h00 | Welcome Reception in the Exhibition Area | ||||||||||||||||||||||
| Monday, 27 September 2021 | |||||||||||||||||||||||
| 07h30–18h30 | Congress registration | 07h30–08h00 Morning run | 09h00–16h30 Exhibition | ||||||||||||||||||||
| 08h30–09h30 |
Bo Holmstedt Memorial Fund Lecture Shana Sturla, ETH Zürich, Zurich, Switzerland |
||||||||||||||||||||||
| 09h30–10h00 | Coffee Break, Exhibition & Poster Viewing 1 | ||||||||||||||||||||||
| 10h00–12h00 |
Session 01 The effect of chemicals on the gut microbiota: is it the cause of all problems? |
Session 02 In vitro organotypic models for predicting the toxicity of chemicals or drugs |
Session 03 Artificial intelligence and machine learning in chemical risk assessment |
Session 04 Personalized nano-immunotoxicology for the workplace |
Session 05 The use of minipigs in juvenile studies in an evolving regulatory landscape |
Short Oral Communications I | |||||||||||||||||
| 12h00–13h00 | Lunch Break & Exhibition | ||||||||||||||||||||||
| 12h00–13h00 | Lunch Industry Symposium | Lunch Industry Symposium | Lunch Industry Symposium | ||||||||||||||||||||
| 13h00–14h00 | Poster Viewing 1 | ||||||||||||||||||||||
| 14h00–15h00 |
EUROTOX-SOT Debate Alan Boobis (EUROTOX debater) and Syril Pettit (SOT debater) |
||||||||||||||||||||||
| 15h00–15h30 | Coffee Break, Exhibition & Poster Viewing 1 | ||||||||||||||||||||||
| 15h30–17h30 |
Session 06 Human induced pluripotent stem cell (iPSC)-based test systems for future mechanism-based chemical safety testing |
Session 07 Setting the European Environment and Health Research Agenda, 2020-2030: the HERA project |
Session 08 Back-translation from clinical outcomes, how did investigative toxicology, modelling and simulation actually perform? |
Session 09 Increasing confidence in non-animal approaches for regulatory decision-making |
Session 10 Computational modeling of AOP networks to assist risk assessment of chemicals |
Short Oral Communications II | |||||||||||||||||
| 17h30–18h30 | COVID-19 presentation (TBA) |
||||||||||||||||||||||
| 18h30–19h30 | Specialty Section Meetings | ||||||||||||||||||||||
| 18h30–19h30 | Young Scientists Meeting | ||||||||||||||||||||||
| Social Reception (TBA) |
|||||||||||||||||||||||
| Tuesday, 28 September 2021 | |||||||||||||||||||||||
| 07h30–18h30 | Congress registration | 07h30–08h00 Morning run | 09h00–16h30 Exhibition | ||||||||||||||||||||
| 08h30–09h30 | SOT Merit Award Lecture | ||||||||||||||||||||||
| 09h30–10h00 | Coffee Break, Exhibition & Poster Viewing 2 | ||||||||||||||||||||||
| 10h00–12h00 |
Session 11 Emerging tools for the investigation and prediction of liver toxiciy |
Session 12 Application of high throughput transcriptomics in mechanism-based chemical safety assessment |
Session 13 Modes of action in non-genotoxic carcinogenesis |
Session 14 New approaches using in vitro assays and 3D models can improve prediction of immune reactions to xenobiotics |
Session 15 Impact of climate change on food safety |
Industry Symposium | |||||||||||||||||
| 12h00–13h00 | Lunch Break & Exhibition | ||||||||||||||||||||||
| 12h00–13h00 | Lunch Industry Symposium | Lunch Industry Symposium | Lunch Industry Symposium | Industry Symposium | |||||||||||||||||||
| 13h00–14h00 | Poster Viewing 2 | ||||||||||||||||||||||
| 14h00–15h00 | HESI Lecture | ||||||||||||||||||||||
| 15h00–15h30 | Coffee Break, Exhibition & Poster Viewing 2 | ||||||||||||||||||||||
| 15h30–17h30 |
Session 16 Human microengineered organs-on-chips: advancing regulatory science through innovation |
Session 17 Designing toxicology studies to support development of cell-based therapies |
Session 18 Mechanistic toxicology as the basis for modelling and prediction of organ-specific toxicity |
Session 19 Can we panelize seizure? |
Session 20 Modernizing cancer risk assessment: beyond the bioassay |
Industry Symposium | |||||||||||||||||
| 19h30–0h00 | Congress Dinner at Langelinie Pavillonen | ||||||||||||||||||||||
| Wednesday, 29 September 2021 | ||||||||||||||||||||||
| 08h00–13h00 | Congress Registration | 09h00–12h00 Exhibition | ||||||||||||||||||||
| 08h30–09h30 |
Keynote Lecture 02 “Genetics load the gun, but environment pulls the trigger” – the human early-life exposome Martine Vrijheid, ISGlobal, Barcelona, Spain |
|||||||||||||||||||||
| 09h30–11h30 |
Session 21 Drug – exposome interactions |
Session 22 Computational models to reliably predict chemical mixture toxicity |
Session 23 The value of micro-physiological systems for drug safety assessment – a series of case studies |
Session 24 Building confidence in the use of New Approach Methodologies for safety decision-making |
Session 25 Safeguarding female reproductive health across disciplines |
|||||||||||||||||
| 11h30–12h00 | Coffee Break & Exhibition | |||||||||||||||||||||
| 12h00–14h00 |
Session 26 Computational toxicology – new advances and acceptance in academia, industry and regulation |
Session 27 Predictive systems to identify etiological factors and pathogenic mechanisms of neurodegeneration |
Session 28 Preclinical immune-safety evaluation of immuno-oncology therapies |
Session 29 The Human Health risk to PFAS exposure |
Session 30 Revisiting paracetamol-induced multisystem toxicity: Novel mechanistic insights |
|||||||||||||||||
| 14h00–14h30 | Closing Ceremony and Awards Presentation | |||||||||||||||||||||
